Psyence Biomedical Ltd.
Psyence Biomedical Ltd. (PBM): ~38 mo cash runway. Updated within the last hour.
BioSniper Score
2-factor signal · derived from public data
38.1 months
D/E 0.08 · 0% dilution
N/A
N/A
N/A
N/A
A transparent, data-derived signal for Psyence Biomedical Ltd.across cash runway, pipeline maturity & breadth, catalyst momentum and clinical/regulatory footprint. Each factor traces to tracked public filings — not an investment recommendation.
Key Financials
Market Cap
$7.2M
Cash
$7.1M
Quarterly Burn
$575K
Runway
38.1 mo
Revenue
—
Cash Runway vs Catalysts
Tracked catalysts land within the current projected cash runway.
Institutional Holdings
Source: SEC Form 13F · as of Mar 2026Institutional holders
1
Total value held
$218
| Holder | Shares | Value |
|---|---|---|
| stonehage fleming financial services holdings ltd | 89 | $218 |
Frequently asked questions
What is Psyence Biomedical Ltd.'s cash runway?
Based on its most recent reported cash balance and quarterly burn rate, Psyence Biomedical Ltd. has approximately 38.1 months of cash runway.
What is Psyence Biomedical Ltd.'s market capitalization?
Psyence Biomedical Ltd.'s market capitalization is approximately $7.2M.
Who is the CEO of Psyence Biomedical Ltd.?
Mr. Jody Aufrichtig is the chief executive officer of Psyence Biomedical Ltd. (PBM).
Get the full picture on Psyence Biomedical Ltd.
Deep pipeline analysis, financial trends, AI-powered investment signals, and real-time catalyst alerts.